Hints and tips:
...A 2009 Supreme Court case involving prescription drug labels, Wyeth v Levine, greenlighted state laws that are stricter than federal laws....
...Compared to J&J, Pfizer has been less theological about holding on to its consumer unit and in recent months has held exploratory discussions with bankers about spinning off or selling the division, which...
...Amgen, which has almost the entirety of its $30bn of cash trapped outside the US, is also holding out for a deal in Washington, according to people close to the group....
...Cultural entrepreneur Philip Dodd is holding his Global Private Museum Summit to coincide with the fair....
...That was what happened in the last big round of consolidation, around the turn of the millennium, through Glaxo Wellcome’s merger with SmithKline Beecham and Pfizer’s with Warner-Lambert and Wyeth....
...You get immediate confrontation of views and discussion,” said Bernard Poussot, the former chief executive officer and president of Wyeth, who was appointed a non-executive director in 2010....
...Mr Read argued that it was impossible for Pfizer to do that without first holding talks to understand AstraZeneca’s case for a higher price....
...Cost savings from its last big deal – the takeover of Wyeth in 2009 – are difficult to measure, as is so often the case for anyone trying to analyse the consequences of a deal....
...They insist that the administration is deliberately holding up assistance to Ukraine by tying it artificially to the broader issue of IMF reform, which they see as unrelated....
...Nestlé’s Wyeth Nutrition unit and Meiji Dairies of Japan were also spared....
...In the previous decade, companies tended to fill holes in sales through large acquisitions, such as Merck’s $41bn purchase of Schering-Plough, and Pfizer’s of Wyeth in 2009 for $68bn....
...Two foreign companies, Nestlé’s Wyeth Nutrition unit and Meiji Dairies of Japan, were also included in the NDRC’s probe but were not penalised....
...In court papers, prosecutors allege that the hedge fund founder sold all of his holdings of Elan and Wyeth stock, worth $700m, after a 20-minute phone call with Mr Martoma....
...Mr Cohen and Mr Martoma made no changes to their holdings, the complaint said....
...But much recent activity has instead focused on divestments, including spinoffs by Pfizer in the wake of its Wyeth purchase and by GlaxoSmithKline of some consumer products....
...Pfizer’s $68bn deal to buy Wyeth had a $4.5bn reverse break fee attached....
...Other industry mega-mergers, such as Pfizer’s $68bn acquisition of Wyeth last year, are still unproven....
...Isomeride, a related compound, was withdrawn in the US in 1997, triggering litigation for Wyeth, Servier’s partner, and a fresh examination of benfluorex....
...Pfizer, the market leader by sales, has announced 19,00 job cuts following last year’s $68bn Wyeth takeover....
...Mr Kindler told the Financial Times last year: “I believe in holding people accountable.”...
...He said the impact of US healthcare reform would depress sales by $300m this year, $900m in 2011 and $800m in 2012, but maintained its medium-term guidance on other financial measures, holding its adjusted...
...The pharmaceuticals company said that full-year profit would be at the top end of its previous forecast of $2.10 to $2.20 per share, due to synergies from last year’s merger with Wyeth....
...have reduced in-house expenditure and closed some disease-research units in the past few months, partly to reduce duplication following a series of large-scale acquisitions such as Pfizer’s takeover of Wyeth...
...For example, one rationale behind Pfizer’s takeover of Wyeth last year was to defer the pain of patent expiries....
International Edition